How gut bacteria pave the road from high-fat diet to heart disease

Robust new research, published in the journal Science, has revealed a microbial mechanism connecting obesity with heart disease. The study describes how a high-fat diet damages intestinal cells, leading to an imbalance of bad bacteria that produce meta… Continue reading How gut bacteria pave the road from high-fat diet to heart disease

WHO begins global trial testing trio of drugs to treat severe COVID-19

The World Health Organization is launching a large-scale global clinical trial testing whether a trio of pre-existing drugs can be repurposed to treat those hospitalized with severe COVID-19. The project serves as the second phase of WHO’s Solidarity p… Continue reading WHO begins global trial testing trio of drugs to treat severe COVID-19

Moderna COVID-19 vaccine safe & effective for teens, clinical trial finds

The results of a large Phase 3 trial testing Moderna’s COVID-19 vaccine in 12 to 17 year olds have been published in The New England Journal of Medicine. The study indicates the vaccine is as safe and effective as it was previously found to be in adult… Continue reading Moderna COVID-19 vaccine safe & effective for teens, clinical trial finds

Blood, brains and burgers: The future is lab-grown everything

Science fiction has long floated the idea of a device that can produce any kind of object one can imagine. Star Trek called it a replicator, while other writers have referred to it as a Santa Claus Machine.Continue ReadingCategory: TechnologyTags: Lab … Continue reading Blood, brains and burgers: The future is lab-grown everything

CRISPR therapy for rare blood disease delivers “life-changing” results

New data from the United States’ first CRISPR gene editing clinical trial indicates the treatment is safe and effective more than two years after initial dosing. Targeting a pair of rare genetic blood diseases, the experimental therapy has so far been … Continue reading CRISPR therapy for rare blood disease delivers “life-changing” results

Long-lasting immune abnormalities detected in recovered COVID-19 patients

New Australian research is offering a thorough look at the lasting impact of COVID-19 on immune system activity. Tracking a wide variety of biomarkers the research found immune abnormalities persisting at least six months after patients recover from ac… Continue reading Long-lasting immune abnormalities detected in recovered COVID-19 patients

Gut bacteria from young mice reverse signs of brain aging in old mice

New research published in the journal Nature Aging is offering some of the first insights into how gut bacteria can potentially influence brain aging in mammals. The study found fecal transplants from young to old mice reversed some aspects of age-rela… Continue reading Gut bacteria from young mice reverse signs of brain aging in old mice

Novavax positions its COVID-19 vaccine as “universal booster of choice”

Biotech company Novavax has announced it will be initially prioritizing regulatory submissions for its promising COVID-19 vaccine in countries with urgent needs such as India, Indonesia and the Philippines. The long-anticipated vaccine is also being tr… Continue reading Novavax positions its COVID-19 vaccine as “universal booster of choice”

New insight into how light therapy can speed up burn wound healing

A compelling new study is offering an insight into the mechanism by which a novel form of light therapy can speed the healing of burn injuries. The research indicates the experimental therapy can activate a key protein that stimulates cell growth.Conti… Continue reading New insight into how light therapy can speed up burn wound healing

Triple-combo of drugs targeting pancreatic cancer looks to human trials

Impressive new preclinical work from a team at MIT has found a combination of three experimental immunotherapy drugs could help shrink, or even eliminate, pancreatic tumors. Each of the three drugs have demonstrated safety in early-stage human trials a… Continue reading Triple-combo of drugs targeting pancreatic cancer looks to human trials